CLOV Stock Overview
Clover Health Investments, Corp. provides medicare advantage plans in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Clover Health Investments, Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.69 |
| 52 Week High | US$1.63 |
| 52 Week Low | US$0.61 |
| Beta | 1.85 |
| 1 Month Change | -8.15% |
| 3 Month Change | -30.16% |
| 1 Year Change | -14.20% |
| 3 Year Change | -91.94% |
| 5 Year Change | n/a |
| Change since IPO | -93.19% |
Recent News & Updates
Recent updates
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Clover Set To Report Earnings Tonight: Levels To Watch
May 09Analysts Are Betting On Clover Health Investments, Corp. (NASDAQ:CLOV) With A Big Upgrade This Week
Mar 04Good News From Clover Health
Feb 25Clover Health Is Now Undervalued, But Gains Not Guaranteed
Jan 24Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out
Dec 03Shareholder Returns
| CLOV | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.2% | -2.3% | 0.7% |
| 1Y | -14.2% | -0.01% | 23.9% |
Return vs Industry: CLOV underperformed the US Healthcare industry which returned -0% over the past year.
Return vs Market: CLOV underperformed the US Market which returned 23.9% over the past year.
Price Volatility
| CLOV volatility | |
|---|---|
| CLOV Average Weekly Movement | 8.0% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CLOV's share price has been volatile over the past 3 months.
Volatility Over Time: CLOV's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 552 | Andrew Toy | www.cloverhealth.com/en/ |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Clover Health Investments, Corp. Fundamentals Summary
| CLOV fundamental statistics | |
|---|---|
| Market cap | US$319.54m |
| Earnings (TTM) | -US$213.36m |
| Revenue (TTM) | US$2.04b |
0.2x
P/S Ratio-1.6x
P/E RatioIs CLOV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLOV income statement (TTM) | |
|---|---|
| Revenue | US$2.04b |
| Cost of Revenue | US$1.78b |
| Gross Profit | US$259.85m |
| Other Expenses | US$473.21m |
| Earnings | -US$213.36m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -0.43 |
| Gross Margin | 12.76% |
| Net Profit Margin | -10.48% |
| Debt/Equity Ratio | 0% |
How did CLOV perform over the long term?
See historical performance and comparison